Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
HIV/AIDS (Auckland, N.Z.)
|
November 19, 2011
Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
Roger Bedimo
Current HIV/AIDS Reports
|
July 17, 2008
Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era
Roger Bedimo
The American Journal of Medicine
|
June 28, 2003
Recurrent extraintestinal clostridium difficile infection
Roger Bedimo, Jeffrey Weinstein
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS
|
February 16, 2019
Single-Tablet Regimens in the Treatment of HIV-1 Infection
James Cutrell, Roger Bedimo
Current HIV/AIDS Reports
|
June 8, 2013
Non-AIDS-defining cancers among HIV-infected patients
James Cutrell, Roger Bedimo
Current HIV/AIDS Reports
|
September 7, 2016
Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients
Roger Bedimo, Oladapo Abodunde
Nature Reviews. Endocrinology
|
March 27, 2013
Increased fracture risk with HIV infection--a growing concern
Roger Bedimo, Pablo Tebas
The New England Journal of Medicine
|
August 16, 2023
Rifapentine in Household Contacts of Patients with Leprosy
Rie R Yotsu, Roger Bedimo
HIV Clinical Trials
|
November 5, 2016
Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection
Roger Bedimo, Lisa Rosenblatt, Joel Myers
Therapeutic Advances in Infectious Disease
|
February 4, 2020
The management of treatment-experienced HIV patients (including virologic failure and switches)
James Cutrell, Tomasz Jodlowski, Roger Bedimo
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
HIV/AIDS (Auckland, N.Z.)
|
November 19, 2011
Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
Roger Bedimo
Current HIV/AIDS Reports
|
July 17, 2008
Non-AIDS-defining malignancies among HIV-infected patients in the highly active antiretroviral therapy era
Roger Bedimo
The American Journal of Medicine
|
June 28, 2003
Recurrent extraintestinal clostridium difficile infection
Roger Bedimo, Jeffrey Weinstein
Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS
|
February 16, 2019
Single-Tablet Regimens in the Treatment of HIV-1 Infection
James Cutrell, Roger Bedimo
Current HIV/AIDS Reports
|
June 8, 2013
Non-AIDS-defining cancers among HIV-infected patients
James Cutrell, Roger Bedimo
Current HIV/AIDS Reports
|
September 7, 2016
Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients
Roger Bedimo, Oladapo Abodunde
Nature Reviews. Endocrinology
|
March 27, 2013
Increased fracture risk with HIV infection--a growing concern
Roger Bedimo, Pablo Tebas
The New England Journal of Medicine
|
August 16, 2023
Rifapentine in Household Contacts of Patients with Leprosy
Rie R Yotsu, Roger Bedimo
HIV Clinical Trials
|
November 5, 2016
Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection
Roger Bedimo, Lisa Rosenblatt, Joel Myers
Therapeutic Advances in Infectious Disease
|
February 4, 2020
The management of treatment-experienced HIV patients (including virologic failure and switches)
James Cutrell, Tomasz Jodlowski, Roger Bedimo
Page
of 9